PREVIEW
Most experts believe that with appropriate management, asthma is an eminently treatable condition. Yet recent studies of practice standards have indicated that many physicians do not treat their patients optimally, prescribing too much “reliever” (bronchodilator) therapy and too little “controller” (anti-inflammatory) therapy. Dr Keenan discusses current trends in asthma management, including the role of a promising new class of drugs, the anti-leukotriene agents.